Pemphigus Foliaceus in Dogs: Welfare Management

Key Welfare Considerations

• Pemphigus foliaceus involves autoantibodies targeting desmoglein-1 in the superficial epidermis.
• Clinical welfare signs include pustules, crusts, scale, and erosions primarily affecting the face and ears.
• Depigmentation, alopecia, and secondary bacterial infection compound welfare suffering.
• Chow Chows, Akitas, Dachshunds, and Spaniels have breed predispositions to pemphigus foliaceus.
• Sunlight exacerbation is documented — UV exposure worsens welfare disease activity.
• Diagnosis requires skin cytology and biopsy — acantholytic cells confirm autoimmune welfare diagnosis.
• Immunosuppressive therapy with prednisolone is the primary welfare treatment.
• Azathioprine is used as a steroid-sparing welfare adjunct to reduce prednisolone side effects.
• Ciclosporin provides welfare benefit in refractory pemphigus through calcineurin inhibition.
• Chlorambucil provides welfare treatment for severe cases or those intolerant of azathioprine.
• Pain management is important — active pemphigus causes significant welfare skin pain.
• Secondary bacterial infection from disrupted skin barrier requires welfare antibiotic management.
• Sunscreen application and sun avoidance reduces welfare UV exacerbation of facial lesions.
• Long-term welfare management is typically required — many dogs achieve remission but need ongoing monitoring.
• Quality of life welfare assessment should guide treatment intensity in this chronic welfare condition.